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Background: The weight loss induced by bariatric surgery (BS) improves asthma clinical control evalu-
ated usually after a short time. The long-term effects of weight loss attained by BS on asthma control and
health related-quality of life (HRQoL) in patients affected by asthma and obesity are not known.
Objective: To investigate the ﬁve-year effect of weight reduction induced by BS on asthma control,
quality of life and pulmonary functional parameters in severely obese intermittent or mild-to-moderate
asthmatic patients.
Methods: Twenty-six consecutive severe obese subjects with previous diagnosis of asthma with indi-
cation for laparoscopic adjustable gastric banding (LAGB) were enrolled into the study. Fifteen of them
agreed to undertake the surgery (treatment group, TG) while the remaining eleven non-operated pa-
tients represented the control group (CG). Body mass index (BMI), Asthma Control Test (ACT), Mini
Asthma Quality of Life Questionnaire (mini-AQLQ) and spirometric parameters were evaluated at
baseline and after one and ﬁve years from surgery.
Results: Mean BMI of TG signiﬁcantly decreased at one and ﬁve years after the surgery, while it remained
unchanged in CG. After surgery, both the overall ACT and the mini-AQLQ score signiﬁcantly improved in
TG after one year, persisting improved after 5-years (p < 0.001), while these outcomes remained un-
changed in CG. As compared with the pre-surgery values, the percentage of predicted FEV1 and FVC
signiﬁcantly increased at ﬁve-year follow-up from surgery in TG, while it remained unchanged in CG.
Conclusions: In severe obese asthmatic patients, the signiﬁcant improvement of asthma control test and
HRQoL, observed one year after LAGB, persists ﬁve years after surgery.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Obesity is a global problem, with several effects on the respi-
ratory system, predisposing to serious respiratory diseases,sthma Quality of Life Ques-
V1, forced expiratory volume
elated-quality of life; LAGB,
nary function test measure-
Telese Terme, BN, Italy.
. Maniscalco).including asthma [1]. Several epidemiological studies have re-
ported the association between obesity and asthma [2e4], indi-
cating an increase in asthma severity and exacerbation [5e7],
therefore burdening patient's quality of life [8] and asthma control
[9,10]. Recently, the respiratory metabolic phenotype (also called
“metabotype”) of obese asthmatic patients has been investigated
by metabolomics [11,12]. It was demonstrated that asthma associ-
ated with obesity express a respiratory metabotype that is fully
different, not summatory, with respect to those separately char-
acterizing patients with either asthma or obesity alone.
Weight loss may improve lung function, asthma control and
M. Maniscalco et al. / Respiratory Medicine 130 (2017) 69e7470severity in adult obese asthmatics [13e16]. In particular, weight
loss induced by bariatric surgery appears to be an effective tool to
improve asthma control and symptoms, although the effect has
been usually evaluated after a relatively short period [15,17e20].
Accordingly, in a one-year prospective study we demonstrated an
improvement in asthma control and lung function in a group of
asthmatic obese patients after weight lost induced by surgical
treatment [21]. The few long-term studies (5 years) published so
far evaluated only the percentage of asthma resolution, without
considering symptoms, control or functional parameters [19,22,23].
In particular, the persistence or the reversibility of the effect
induced by weight loss after long term from the bariatric surgery is
not known.
In this paper, we investigated the long-term (ﬁve-year) effects of
weight loss induced by bariatric surgery on asthma control and the
health-related quality of life (HRQoL) and lung function in severe
obese asthmatic patients.
2. Materials and methods
2.1. Patients
Twenty-six consecutive severe obese subjects with previous
diagnosis of intermittent or mild-to-moderate asthma attending
our bariatric surgery clinic (tertiary care) for laparoscopic adjust-
able gastric banding (LAGB) evaluationwere enrolled into the study
from April 2010 to April 2011. Fifteen of them agreed to undertake
the surgery (treatment group, TG), while the remaining eleven,
which refused for reasons unrelated to asthma or other health
problems, represented the control group (CG).
All patients were non-smoker or had stopped smoking for two
years or more. The diagnosis of asthma was made following the
American Thoracic Society criteria [24]. Atopy was based on posi-
tive wheal responses (>3 mm) to 12 common airborne allergen
extracts (Dermatophagoides farinae and Dermatophagoides pter-
onyssinus and dog and cat dander), pollens (Gramineae, Parietaria
species, Betulaceae, Artemisia and Oleaceae), andmould (Aspergillus,
Alternaria and Cladosporium) using a standardized skin prick test kit
(Allergopharma Hamburg, Germany). Exclusion criteria included
the following: cardio-respiratory disturbances, obstructive sleep
apnea, and history of upper respiratory tract infection or relevant
allergen exposure within 4 weeks before entering the study.
The local Ethics Committee approved the study protocol and
informed written consent was obtained.
2.2. Outcomes
Six outcome parameters were considered. The Body Mass Index
(BMI), the Asthma Control Test (ACT), the Mini Asthma Quality of
Life Questionnaire (Mini-AQLQ) and three pulmonary functions
(PFTs) (FEV1, FVC, FEV1/FVC).
2.3. Pulmonary function test measurements
Flow rates were determined using automated equipment (V
Max 22 System SensorMedics, Milan, Italy). Forced inspiratory and
expiratory maneuvers were performed three times and the best
value obtained from themaximum inspiratory and expiratory ﬂow-
volume curves were used for comparison. Recommendations for
standardized procedures for various lung function tests were fol-
lowed [25].
2.4. Asthma control and HRQoL
To assess the asthma control and HRQoL we used the ACT andthe mini-AQLQ, respectively. The ACT consists of ﬁve questions,
each with a ﬁve-point scale assessing asthma symptoms (daytime
and nocturnal), use of rescue medications, and the effect of asthma
on daily functioning [26]. The score ranges from 5 to 25, with lower
scores indicating poorer asthma control. Subjects with an ACT score
<20 were deﬁned as having not well-controlled asthma. The mini-
AQLQ consists of 15 questions on symptoms, activity limitations,
emotional function and environmental stimuli, each with a 7-point
scale [27]. The score ranges from1 to 7, with lower scores indicating
poorer HRQoL.
2.5. Experimental procedure
The PFTs, ACT questionnaire and mini-AQLQ were performed
before surgery, and repeated one and ﬁve years after the surgery in
TG; at baseline and after one and ﬁve years in CG. All measurements
were carried out at lunchtime. All subjects were fasted for 4 h
before the tests. The subjects' weight and height were measured
immediately before the start of the experiment. Patients with al-
lergy to pollen were studied out of season. The dose and timing of
long-acting b2-agonists were identical at study visits before and
after weight loss. Patients did not consume any short-acting
bronchodilators for 4 h before pulmonary function tests.
2.6. Statistics
Continuous variables are expressed as mean ± standard devia-
tion (SD) while categorical variables are expressed as rates. To
evaluate the effect of the treatment at each follow-up time and the
possible changes between follow-up times in each treatment
group, we performed a multiple regression using as dependent
variables the differences between each follow-up time and the
baseline of each outcome. Being aware that the errors of the mul-
tiple (six) regression models have a great probability of being
correlated, we analyzed our data by applying a “seemingly unre-
lated regression” model (SUR) [28] with the relative multivariate
analysis of covariance (MANCOVA) (see Supplemental Data). A one-
way multiple analysis of variance (MANOVA) model was used to
test the differences on baseline parameters between the group of
patients undergoing surgery and the control group. A one-way
analysis of variance (ANOVA) on the items composing the ACT
and mini-AQLQ scores changes was employed to assess whether
changes observed in the global scores were attributable to one or
more speciﬁc item. Data were analyzed by Stata version 13.0 (Sta-
taCorp LP, College Station, Texas). Statistical signiﬁcance was
accepted at p < 0.05.
3. Results
Baseline characteristics of patients are shown in Table 1. No
signiﬁcant differences were observed on baseline values of age and
the six outcome variables between treatment and control groups
(p ¼ 0.26). Furthermore, no signiﬁcant differential behavior in any
of the items composing the ACT and the mini-AQLQ global score
was observed between the two groups (always p > 0.6; Table 2).
The MANCOVA analysis shows that the main effect of the sur-
gery (treatment) is signiﬁcant (p  0.0001) without differences
between the four statistics (Wilk's lambda, Lawley-Hoteling trace,
Pillai's trace and Roy's largest root). While the main effect of the
follow-up time is not signiﬁcant (p¼ 0.088), its interactionwith the
surgery is signiﬁcant (p ¼ 0.008). Interestingly, the model includes
a signiﬁcant effect of age as confounder. The lack of signiﬁcance of
the follow-up time (p ¼ 0.088) does not imply that signiﬁcant
differences related to follow-up cannot be observed since the
interaction term is actually signiﬁcant. Therefore, speciﬁc time
Table 1
Characteristics of patients at baseline and after one and ﬁve years.
Baseline 1 year 5 years
CG
N ¼ 11
TG
N ¼ 15
CG
N ¼ 11
TG
N ¼ 15
CG
N ¼ 11
TG
N ¼ 15
Sex (M/F) 0/11 3/12 0/11 3/12 0/11 3/12
Age (yr.) 34.4 ± 13.3 34.3 ± 9.4 35.5 ± 13.1 35.4 ± 9.2 39.2 ± 13.1 39.1 ± 10.2
Atopy (yes/no) 9/3 13/2 9/3 13/2 9/3 13/2
Smoking History 9 N, 2 E 14 N, 1 E 9 N, 2 E 14 N, 1 E 9 N, 2 E 14 N, 1 E
Weight (kg) 115.4 ± 11.8 119.8 ± 17.5 115.4 ± 11.8 93.1 ± 13.6 112.9 ± 11.4 79.7 ± 7.2
BMI (kg/m2) 43.4 ± 3.7 44.2 ± 5.3 42.1 ± 2.3 34.3 ± 3.3 42.5 ± 4.0 29.4 ± 2.1
FEV1/FVC 0.75 ± 0.07 0.77 ± 0.09 0.77 ± 0.06 0.8 ± 0.08 0.76 ± 0.05 0.8 ± 0.06
FEV1% pred 87.7 ± 13.4 83.9 ± 9.7 86.7 ± 10.7 86.1 ± 7.9 83.7 ± 8.9 88.8 ± 8.6
FVC % pred 101.9 ± 13.5 95.8 ± 6.3 98.3 ± 8.9 96.4 ± 5.9 99.0 ± 12.0 97.8 ± 8.5
BMI ¼ body mass index; CG ¼ obese asthmatic not operated; E ¼ ex-smoker; F ¼ female; FEV1 ¼ forced expiratory volume in 1s; FVC ¼ forced volume capacity; M ¼ male;
N ¼ non-smoker; TG ¼ obese asthmatic who underwent bariatric surgery.
Table 2
Asthma control test (ACT) and mini Asthma Quality of Life Questionnaire (mini-AQLQ) in the patients at baseline and after one and ﬁve years.
Baseline 1 year 5 years
CG
N ¼ 11
TG
N ¼ 15
CG
N ¼ 11
TG
N ¼ 15
CG
N ¼ 11
TG
N ¼ 15
ACT total score 19.0 ± 2.0 17.8 ± 3.0 18.8 ± 2.0 21.4 ± 1.8 19.1 ± 1.8 21.8 ± 2.0
Asthma keeps you from getting much done at work/school 4.2 ± 0.7 3.8 ± 0.7 4.1 ± 0.5 4.4 ± 0.6 4.0 ± 0.6 4.4 ± 0.6
Shortness of breath 3.2 ± 0.6 3.2 ± 0.6 3.4 ± 0.7 4.1 ± 0.6 3.5 ± 0.8 4.2 ± 0.6
Asthma symptoms wake you up 4.1 ± 0.8 3.8 ± 0.8 3.9 ± 0.7 4.2 ± 0.6 4.0 ± 0.8 4.5 ± 0.6
Use of rescue medication 3.7 ± 0.6 3.8 ± 0.9 3.7 ± 0.6 4.4 ± 0.5 3.7 ± 0.8 4.5 ± 0.5
Patient rating of control 3.8 ± 0.7 3.6 ± 0.6 3.7 ± 0.6 4.3 ± 0.6 3.9 ± 0.7 4.3 ± 0.6
MiniAQLQ score 4.1 ± 0.7 4.1 ± 0.9 4.1 ± 0.6 5.4 ± 0.5 3.9 ± 0.6 5.3 ± 0.6
Symptoms 4.1 ± 1.1 4.0 ± 1.1 4.1 ± 0.9 5.4 ± 0.9 3.9 ± 1.0 5.2 ± 1.0
Emotional 4.2 ± 0.8 4.2 ± 0.8 4.1 ± 0.8 5.4 ± 0.8 4.2 ± 0.6 5.4 ± 0.8
Environmental 4.4 ± 1.0 4.4 ± 0.9 4.5 ± 0.9 5.5 ± 0.7 4.1 ± 0.7 5.5 ± 0.7
Activity 3.5 ± 0.9 3.8 ± 1.0 3.7 ± 0.8 5.3 ± 0.6 3.4 ± 0.8 5.0 ± 0.8
CG ¼ obese asthmatic not operated; TG ¼ obese asthmatic who underwent bariatric surgery.
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the signiﬁcant threshold. As expected, there was a signiﬁcant
(Breush-Pagan test p  0.001) correlation among the residuals of
the six outcome regressions, thus, the use of the SUR analysis was
justiﬁed. Table 3 shows that the outcome changes with the most
relevant fraction of variation explained by the independent factors
is, as expected, the BMI followed by the mini-AQLQ score (75.2%
and 55.6% respectively). The ACT score accounts for the 33.3% and
the pulmonary function measures span from 29.1% to 46.2%. The
single contrasts of interest signiﬁcance between treatment levels of
the changes from baseline (delta) of the six outcomes at each
follow-up stage are overlaid on the plots reported in Fig. 1. Panel A
shows that the changes of the mini-AQLQ index from baseline at 1
year in the treatment group are signiﬁcantly greater than those
observed in the control group. Moreover, this improvement re-
mains unchanged 5 years after the surgery. Same behavior is
evident in panel B from the ACT score. The expected BMI reduction
one year after surgery (panel C) is signiﬁcantly more prominent ﬁve
years after treatment, and contrasts with the BMI stability observed
in the control group. Panels from D to F report the behavior of the
changes of the pulmonary function as indicated by FEV1, FVC and
FEV1/FVC ratio. The statistically signiﬁcant difference is only
observed after ﬁve years of follow-up between treated and control
group.
4. Discussion
The data reported indicate that in severe obese asthmatic pa-
tients, the signiﬁcant improvement of asthma control score and
asthma HRQoL index, observed one year after LAGB, persist ﬁveyears after surgery. Of note is that the persistent BMI reduction ﬁve
years after treatment is signiﬁcantly lower than that observed at
one year in treated patients. This reduction may trigger, at least in
part, the rise of a signiﬁcant treatment effect observed for func-
tional indices ﬁve years after surgery.
To examine the long-term effect of weight reduction induced by
bariatric surgery on asthma control and asthma HRQoL, we used
ACT and mini-AQLQ. The questionnaires have been fully validated
for use in both clinical practice and trials, and are precise mea-
surement instruments able to detect small but clinically important
changes that patients experience as a result of treatment or natural
ﬂuctuation in their asthma [26] [27].
In our study, at one year from the surgery, TG reported a sig-
niﬁcant ACT improvement in all ﬁve questions, conﬁrming the re-
sults obtained in a different group of obese asthmatic patients [21].
As compared to CG, a higher score inmini-AQLQ for TG patients was
also found after the surgery, which was apparent in the total score
and in all domains. Interestingly, the improvement in both ACT and
mini-AQLQ persisted ﬁve years after surgery, although no signiﬁ-
cant difference between one and ﬁve years was found. This could be
explained stating that the maximum effect is reached in one year
and steadilymaintained through ﬁve years. On the other hand, such
a stability could also be related to the criteria to evaluate the out-
comes, as theymay become “insensitive” and/or “aspeciﬁc” beyond
a threshold, having reached a ceiling effect after one year. In gen-
eral, as clearly stated: “Disease-speciﬁc quality-of-life question-
naires are designed to measure the problems that are most
important to the majority of patients, but patients are heteroge-
neous in their experiences and priorities and no questionnaire can
cover all of the problems experienced by all patients. The more that
Table 3
Seemingly unrelated Regressions (SUR) analysis.
Dependent Var. Independent Var. Coeff.±SE P
Delta mini-AQLQ
R2 ¼ 55.6%
Treatment 1.25 ± 0.2 0.0001
Follow-Up Time 0.24 ± 0.25 ¼0.34
Interaction: T by FUP 6.7 ± 32.0 ¼0.83
Age 0.006 ± 0.007 ¼0.43
Constant Term 0.15.5 ± 0.31
Delta ACT
R2 ¼ 33.3%
Treatment 3.7 ± 1.1 0.0001
Follow-Up Time 0.3 ± 1.1 ¼0.81
Interaction: T by FUP 0.02 ± 1.5 ¼0.99
Age 0.02 ± 0.03 ¼0.62
Constant Term 0.7 ± 0 .1.3
Delta BMI
R2 ¼ 75.2%
Treatment 9.1 ± 1.3 0.0001
Follow-Up Time 0.27 ± 1.5 ¼0.85
Interaction: T by FUP 4.7 ± 1.9 ¼0.01
Age 0.03 ± 0.04 ¼0.44
Constant Term 2.5 ± 1.8
Delta FEV1/FVC
R2 ¼ 29.1%
Treatment 0.04 ± 0.03 ¼0.14
Follow-Up Time 0.06 ± 0.03 ¼0.07
Interaction: T by FUP 0.07 ± 0.04 ¼0.07
Age 0.001 ± 0.0009 ¼0.12
Constant Term 0.07 ± 0.04
Delta FEV1
R2 ¼ 46.2%
Treatment 0.13 ± 0.06 ¼0.054
Follow-Up Time 0.18 ± 0.08 ¼0.02
Interaction: T by FUP 0.31 ± 0.1 ¼0.002
Age 0.002 ± 0.002 ¼0.51
Constant Term 0.03 ± 0.1
Delta FVC
R2 ¼ 41.3%
Treatment 0.15 ± 0.08 ¼0.07
Follow-Up Time 0.27 ± 0.09 ¼0.003
Interaction: T by FUP 0.28 ± 0.12 ¼0.02
Age 0.007 ± 0.003 ¼0.017
Constant Term 0.33 ± 0.11
Mini-AQLQ¼Mini Asthma Quality of Life Questionnaire; ACT¼ asthma control test;
BMI ¼ body mass index; FEV1 ¼ forced expiratory volume in 1 s; FUP ¼ follow-up;
FVC ¼ forced volume capacity; SE ¼ standard error; T ¼ treatment.
Fig. 1. Plots of changes (Delta) from baseline values of quality of life score (panel A), asthma
E), FVC (panel F) at 1 and 5 years of follow up. Signiﬁcance of the treatment effect at each
Red triangle ¼ treated group, black circle ¼ control group. Panel D Y axis scale is times 100. (
to the web version of this article.)
M. Maniscalco et al. / Respiratory Medicine 130 (2017) 69e7472the number of items in a questionnaire is reduced, themore likely it
is that individual patient problems will be omitted and the in-
strument will lose content validity” [29].
To our knowledge, this is the ﬁrst study that evaluates the long-
term effect of obese asthmatic patients on asthma control, HRQoL
and functional parameters. Several studies have shown a decrease
in the prevalence of asthma after weight loss measured within
short time from surgery (usually one year) [15,17e19]. Spivak [30]
reported a reduction of drugs prescription for each co-morbidities
after surgery. Dixon et al. in an uncontrolled study reported
improvement in all aspects of asthma assessed, including severity,
daily impact, medications needed, hospitalization, sleep and exer-
cise clinical scores in asthmatics obese after bariatric surgery [15].
Accordingly, in a previous one-year prospective study from our
group, we have shown an improvement in asthma control, espe-
cially shortness of breath and use of rescue medication, and lung
function in a different group of asthmatic obese patients after
weight lost induced by surgical treatment [21]. In the long-term
studies performed in a population of obese patients after bariatric
surgery, only the percentage of asthma resolution and the referred
symptoms were evaluated, showing a resolution of this disease of
48% and 87% [19,22,23]. However, in these studies the criteria for
asthma diagnosis, the functional and clinical parameters and the
control and HRQoL were not reported.
In our study, we have also detected an increase in spirometric
values after ﬁve years, which was present only in the TG and not in
CG. These results extend the results of other studies in which the
improvement in lung function, following weight reduction in obese
asthmatics have been reported for one year [15,17e19]. The absence
of a signiﬁcant improvement of functional parameters after one
year in our study might be due to the sample size dimension,
together with the magnitude of the change variation (as measured
by the reported standard deviations), which may, at least in part,control test (panel B), body mass index (panel C), FEV1/FVC ratio (panel D), FEV1 (panel
follow-up and of the time effect at each treatment group are reported.
For interpretation of the references to colour in this ﬁgure legend, the reader is referred
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in those indices.
The improvement of all outcomes we have evaluated after
weight reduction may depend on several factors, including the
improvement in mechanical properties of the airways, the reduc-
tion in systemic and airway inﬂammation and/or the reduction of
co-morbidities [31]. In fact, in obese asthmatic patients early airway
closure is increased during expiration and the lung periphery is
more collapsed [32]. The weight reduction, which reduces closing
capacity and the collapse of lung periphery, tends to improve the
FEV1 and the FVC, reducing the clinical symptoms [33]. Again, the
weight reduction induced by diet [34,35] or bariatric surgery [20]
may reduce airway responsiveness in obese patients with a good
correlation with the reduction of BMI.
The reduction of pro-inﬂammatory mediators such as cytokines
and several adipokines from adipose tissue induced by the weight
loss may contribute the improvement of symptoms and asthma
control [19,36]. Finally, the reduction of obesity-associated
comorbidities due to bariatric surgery (for example, gastro-
esophageal reﬂux disease or hypertension) should also be consid-
ered as a potential mechanism ameliorating symptoms and quality
of live in obese patients [37].
The improvement observed in mini-AQLQ might also be due to
an independent effect of weight loss. In fact, weight-loss in-
terventions are usually accompanied by profound changes in
physical activity and mental health, both of which may have
complex independent effects on mini-AQLQ. In particular, the
increased physical activity might be responsible for the improve-
ment in both mechanical properties of lungs and asthmatic
symptoms such as dyspnea. It is known that increased physical
activity plays a major role in reducing dyspnea both in healthy
people or in patients with respiratory disorders [38]. Thus, it is not
straightforward to determine whether improvements in mini-
AQLQ associated with weight loss are attributable to a reduction
in body fat or, simply, to the metabolic consequences induced by
increased physical activity and improved eating behavior [39].
The subjects involved in the study were consecutively recruited
through the hospital's surgery department from obese patients
scheduled for bariatric surgery, therefore excluding patients with
severe asthma and/or severe comorbidities and complying with the
strict surgical protocol. However, some limitations apply to our
study. First, treatment allocation was not randomized; thus, even if
patients in the control group share with treated subjects equal
surgery indications, overlapping clinical and functional proﬁle and
do not show signiﬁcant differences on baseline parameters, a
possible selection bias cannot be excluded. Second, we did not
evaluate the molecular aspects of weight loss on airway hyper-
reactivity or inﬂammatory status, which could have shed light on
the improvement in spirometric function and asthma symptoms
and control, therefore clarifying the issue of mechanical properties
of the airways and/or the inﬂammation reduction. Third, the
sample size of the study populationwas limited, but because of the
surgical protocol. However, the magnitude of the observed differ-
ences between TG and CG allowed a statistically signiﬁcant detec-
tion. Finally, we have evaluated the obesity only by BMI, which does
not truly reﬂect the real individuals' fat or lean mass [37].
In conclusion, we think that the “durable” asthma control and
HRQoL associated to the persistent weight reduction induced by
laparoscopic adjustable gastric banding may represent an impor-
tant beneﬁt for severe asthmatic patients.Conﬂict of interest
None.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.rmed.2017.06.010.
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